<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 69 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page68.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=69">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 69 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 69</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=69"><img src="../thumb/69.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>38 / 2020-04                                                         Central Nervous System - 1.6
   debilitat., imp.ren./hepat./resp.funct., poss.tol./ depend.with prolong.  (S3) CR TABS, 45/2.5/0411, 0091, 0092  Drug interactions: Mg & Al contain.antacids reduc. bioavail.,
   use, withdr.react.with abrupt. cessat.  718465-001: 200 mg, 100, R296,80  morph.incr.conc.
   Drug interactions: Pharmacokinet.of concom. meds. poss.alt.as liv.  718466-001: 300 mg, 100, R444,96
   enzyme activ.induc., plasma lev. incr.by agents inhibit.CYP450 3A4   718468-001: 500 mg, 100, R736,47  NURIKA, (Cipla Medpro) Teva [P/S]
   enzyme, hepatotox. of paracet.incr., theophyll.affect.free phenobar-  Dosage: Take with food. Do not crush or chew tabs. Admin.once/  Pregabalin
   bit. (Mysoline metabolite) lev., CNS depress. eff.enhanc.by other CNS   twice dly. Dly.dos.vary accord. to age & body mass. Optimum dos.  Indications: Adult neuropath.pain due to H.Zoster infects.& diabet.
   depress., poss. incr. Vit.D catabolism.  main.determ.by seiz.control.  (S5) CAPS. 46/2.5/0772.764, 0774.766, 0775.767
   Warnings: Pot.to harm foet.  Adults:                       723853-001 25 mg, 60, R130,95
                                                              723854-001 75 mg, 60, R329,77
   NAVALPRO 400 mg/4 ml, (Aspen Pharmacare: Pharma)   Epilepsy: Start 600 mg/day where applic in div.dos.incr.by 200 mg/  723855-001 150 mg, 60, R494,66
                                day at 3 day interv.until contr.achiev.gen.betw. 1 000-2 000 mg/day.
   Pharmacare [P/S]             If not stabil.aft.2 wks.may incr.to max.of 2 500 mg/day or one other   Dosage: Recomm.start.dos: 75 mg 2xdly.with/-out food. Bas.on
   Sodium valproate             anti-epilept.add.at low dos.  indiv respons.& tol.dos.may be incr.to 150 mg 2xdly.aft.3-7 day interv.
   Indications: Short-term grand mal, petit mal, mix.gen. & temp.lobe   Treatm.& prev.of mania assoc.with bipol. disords: Recomm.  Discont.grad.over minim.1 wk.
   epilep.treatm.when oral ther.not poss.  init.dos: 1 000 mg/day. Incr.as rapid.as poss.to achiev.low.therapeut.  Contraindications: Safety & effectiven.in pregn./ pts.&lt; 18 yrs.
   (S3) INJ, A40/2.5/0342       dos. produc. desir.clinic.eff. Adjust accord.to indiv.clinic. respons. Est.  not est., breast feed.
   718849-002: 400 mg, sngl.vial & dil., R222,95  prophylact.treatm.indiv.with low. effect. dos.  Side effects: CNS effs.most common of which dizzin. & somnol.,
   Dosage: Pts.need to be switch.to oral ther.as soon clinic. poss.   Contraindications: Pre-exist.liv.dis., hepat. dysfunct.hist., urea cycle   loss of consciousn., confus., ment. impairm., revers.paralys., neutro-
   Admin.by direct slow IV inj./ infus.using separ.IV line in NaCl/dex-  pen., incr. appet., anorex., hypoglycaem., psych./CNS disords., blurr.
   tr.5%/dextr. NaCl.           disords, MAOI, porphyr., pregn.& lactat.,  vis., vis.disturbs., diplop., dry eye, eye swell./-pain/-irrit., mydrias., alt.
                                Side effects: Sev.liv.damage & pancreatit.(with fatalit.), suicide.
   Adults & adolesc: Oral ther.replacem: Cont. with curr.dly.dos.via   vis.depth percept., periph.vis.loss, asthenopia, lacrimat.incr., photop-
                                                                                      st
   contin./repeat.infus.at same freq.as oral dos. Admin.in div.dos.if tot.  ideat.& behav., thrombocytopen., revers.prolong.bleed.time, bone   sia, oscillopsia, strabism., vertigo, hyperacus., tachycard., 1  degr.AV
                                marr.depress., red cell hyperplas., leucopen., isolat.fibrinog.reduct.,
   dly. dos.exceeds 250 mg.                                   block, sinus tachycard., sinus dysrhythm./-bradycard., flush., hypo-/hy-
   Init.expos: 400-800 mg depend.on bm (up to 10 mg/kg) by slow   allerg. reacts., angioed., hyperammonaem. encephalopathy in urea   pertens., periph.coldn., dyspn., nas.dryn., nasopharyngit., cough, nas.
                                cycle disords., hyerglycinaem., psych.disords.incl.amnes./sleep
   IV inj.over 3-5 mins. usual. follow.by contin./ repeat.infus. up to   congest., epistax., rhinit., snor., throat tightn., GI disturbs., sweat., cold
   max. of 2 500 mg/day or one other anti-epilept.agent may be add.   disords./somnol./behav.& mood or ment.changes, atax., trem.,   sweat., papul.rash, musc.twitch./-cramp/-stiffn., joint swell., myalg,.
                                headache, dizzin., abnorm.gait., cataton. reacts., dysarthr., hyper-
   at a low dos.                                              arthralg., neck-/back-/limb pain, rhabdomyolys., cervic.spasm., dysur.,
   Combinat.ther: May be necess.to incr.dos.by 5-10 mg/kg/day when   ton., hypokines., paraesthes., incr.reflex., speech disords., tard.   urin. incontin./retent., oligur., ren.fail., erect. dysfunct., delay.ejaculat.,
   Na valproate used with other anticonvuls.which induc.liv.enzym. Dos.  dyskines., extrapyramid.sympts., incr.alertn., amblyop., nystagmus,   sex.dysfunct., amenorrh., dysmenorrh., breast pain/-discharge, hyper-
   may be reduc.when other agent withdr. Same pattern to be follow. in   spots bef.eyes, diplop., conjunctivit., dry eyes, eye/ear pain, tinnit.,   trophy breast, gynaecomast., fatig., oed./ periph. oed., feel.drunk., ab-
   pts. already receiv.other ther. If incr. sedat. observ., barbits.dos. to be   otit. media, deafn., vertigo, palpitat., tachycard., hypo-/hypertens.,   norm.gait, asthen., fall, thirst, tight chest, exacerbat.pain, pyrex., rig-
   reduc.as that of Navalpro incr. Dos.of both Navalpro & other agents   vasodilat., pharyngit., flu syndr., dyspn., pneumon., bronchit., epistax.,   ors, anasarca, incr.weight., withdr.sympts.aft. discont. of short-term &
   to be adjust.dur.stabilisat.per.giv.optim. contr. at low.poss.combin.dos.  incr.cough, rhinit., sinusit., GI disturbs., haematemes., periodont.   long-term treatm., CHF/deteriorat. HF, resp.fail.& coma with concom.
   lev.& poss.maint. optim.contr. with Navalpro alone.  abscess, alopec., hirsutism, acne, skin & subcutan.tiss.disords.incl.  CNS depress., hypersens. reacts.incl.angioed.& urticar., swollen tong.,
   Childr.dos.(≥ 20 kg): Usual range: 20-30 mg/kg bm/day. Init.dos.  Stev.Johns.syndr., back/neck pain, leg cramps, hyperton., arthralg.,   face swell., Stev.-Johns.syndr., prurit., encephalopathy, incr.alanine
   should be 400 mg/day irrespect.of mass, in div.dos.with spaced dos.  myalg., myasthen., urin.incontin., cystit., revers. defects in ren.tubul.  aminotransfer./ bld. creat. phosphokin./aspart.aminotransfer./bld.
   incr.until contr. achiev. Dos.may be incr.to 35 mg/kg bm/day where   funct., menstrual changes, vag.haemorrh., vaginit., gynaecomast.,   gluc./ bld.creatin., decr.platelet count/bld. K / weight/ WBC count.
                                                                                +
   adeq.contr.not achiev.within the above range. Childr.dos.&lt;20 kg:   infects., asthen., periph.oed., fev.  Warnings and special precautions: Imp.ren. funct., pts.receiv.
   20 mg/kg bm/day. In sev. cases may be incr. but only in pts.in whom   Special precautions: Pts.at high risk of liv. dysfunct. esp.with mul-  haemodialys., incr.accid.injur. partic. in elderly, pts.to familarise
   plasma Navalpro lev.can be monit. Clinic.chemist. & haemolog.para-  tipl.anticonvuls.ther.are infts. & childr.und.3 yrs.with sev.seiz.disords.   themselv.with potent.S/E, CHF, discont.if sympts.of angioed. occur,
   met. to be monit.above 40 mg/kg/day. Elderly & ren.insuffic: Dos.  partic. with brain damage/ment.retard.&./ congenit. metabol.or de-  potent.resp.fail.with concom.antidepress., adjust. of hypoglycaem.
   may need to be reduc.        generat.dis., monit.clinic. sympts.& liv.funct.tests incl.prothromb.rate   meds.poss.req.in diabet. pts. gain.weight dur.treatm., incr.incid.
   Contraindications: Pregn.& lactat., act.liv.dis. incl.ac. & chron.  dur.1st 6 mnths. for early signs of hepat.fail., discont. concom. salicy-  of adv. reacts. in gen./CNS adv.reacts.& esp.somnol.in treatm. of
   hepatit./hepat.dysfunct.hist.esp.if drug relat./ porphyr., concom.  lates as precaut., hepat.fail with pancreatit.incr.fatal outcome risk,   centr.neuropath.pain due to spin.cord inj. poss.due to addit.eff.with
   salicylat.use in childr. und.3 yrs. with incr.liv.enzym., same IV line   sev.liv.damage and pancreatit.risk decr.with age, discont. ther.with   concom.meds., monit. pts.for signs of suicid.ideat.& behav., consid.
   as other IV addit.           pancreatit., monit.for suicid.ideat.& behav., pres.in breast milk, incr.  meas.to prev.constip.with concom.opioids., monit. pts. with hist.of
   Side effects: Bld.dyscras., revers.bleed.time prolongat., SLE, allerg.  incid.of congenit. abnormalit.report.in both untreat.& treat.epilept.,   subst.abuse for sympts.of pregabalin misuse/abuse/depend., poss.
   reacts., skin reacts.incl.tox. epiderm. necrolys./Stev.Johns.syndr./  caref.screen.of pregn.by alpha-foetoprot measurem. & ultrasound,   laxat. eff.from mannitol content
   erythema multiforme/acne, weight gain, hyperammonaem. even in   elderly, ren.insuffic., bld. tests recomm.in spontan.bruis./bleed., eval.  Drug interactions: Addit.to cognit.& gross mot. funct. impairm.
   absence of hepat.impairm., psych.disords., behav.disturbs., stupor/  risk vs.benef.in SLE, false posit.in urin.test.of poss. diabet., suspect.   from oxycodone, effs.of ethanol & lorazepam potent., resp.fail.&
   lethargy somet.lead.to coma, revers.dement.assoc.with cerebr.atro-  urea cycl.enzymat.defic., dent. proced., sched.surg.  coma with concom. CNS depress.
   phy, CNS effs., trem., somnol., extrapyramid.sympt., encephalopathy,   Drug interactions: Effs.of other psychotrop. potent., rais.phenobarb.
   dizzin., hear.loss, oed., vasculit., GI disturbs., gastralg., pancreatit.,   plasma conc., primidone plasma lev.incr., phenytoin tot.plasma conc.  PAMIRAM, (Unicorn) Akacia [P/S]
   polydips., liv. dysfunct.incl. hepat. fail., trans.hair loss, hirsutism, dia-  decr.& phenytoin free form incr., tox.eff.of carbamazep. potent., me-  Topiramate
   phores., irreg.per., amenorrh., gynaecomast., Fanconi’s syndr., polyur.,   tabol.of lamotrig.reduc., zidovud. plasma conc.rais., anti-epilept.eff.  Indications: Adjunct.ther.for adults & childr.over 12 yrs.when inadeq.
   enures., inj.site react., revers. dement./cerebr.atrophy/Parkinson., incr.   antagon.by antidepress. & neurolept.which low.seiz.threshold, ser.   contr.by convent.first line anti-epilept.meds.for part.onset seiz.with/
   foet. malformat./develop.delay in childr.born to epilept. mothers.  conc.decr.by anti-epilept.with enzyme induc. eff., incr.ser.conc.with   without second.gen.seiz., seiz.assoc.with Lennox-Gastaut syndr.&
   Special precautions: Porphyrinogen. in animals, monit.platel.  felbamate, mefloquine incr. valproic acid metabol.& has convuls.  prim. generalis.tonic-clonic seiz.
   funct.bef.maj.surg., LFT bef.init.ther. & per.dur.1  6 mnths.esp.in pts.  eff., chloroquine may low.seiz.threshold, valproate free ser. lev.incr.  (S3) TABS. 42/2.5/0827, 0828, 0829, 0830
                      st
   at risk, metab. test. bef.treatm.init.in susp.urea cycle enzyme.defic.,   by high.prot.bound agents (aspirin), anticoag. eff.of vit.K depend.fact.   716000-001: 25 mg, 60, R190,44
   INR monit.with Vit.K depend.fact. anticoags., poss.incr.in convuls.  anticoags.incr., cimetid. & erythromyc.poss.incr.ser.lev., valproate bld.   716001-001: 50 mg, 60, R359,13
   dur.ther.& decr.on ther.withdr./dos.reduct.oft.dur.combin.ther./aft.   lev.decr.by carbapenem antibiot.  716468-001: 100 mg, 60, R596,88
   sudd. valproate dos.incr., teratogen.effs.report.in animals, excret.in   NEURONTIN, Pfizer [P/S]  716482-001: 200 mg, 60, R1 004,95
   breast milk, do not discont.anti-epilept.ther.sudd.in event of pregn.as   Gabapentin.  Dosage: Init.at low dos.titrat.to effect.dos. Tabs. not to be broken.
   breakthrough seiz.with ser.effs.poss., haemorrh. syndr. incl.poss.fatal   Indications: Adjunct.ther with stand antiepilept. drugs where adeq.  Monother: Discont.grad.at approx.1/3 of concom. admin.antiepilept.
   afibrinogenaem.report.in neonat. whose mothers used Na valproate   contr.has not been achiev. Contr. both simple & complex part.seiz.  med.dos.every 2 wks unless abrupt withdr.reqd.for safety concerns.
   dur. pregn.theref.platel.count/fibrinog.plasma lev./ coagulat.tests &   with/ without second.general.tonic-clonic seiz.  Topiramate lev.will incr.when enzyme.induc.meds.are withdr. Dos.
   fact.monit.in neonat., childr.und. 3 yrs.receiv.concom. anticonvuls.,   (S3) CAPS, 27/2.5/0598, 0599, 0600.   decr.may be reqd if clinic.indic.
   ren.insuff., discont. ther.if pt.devel.pancreatit.& monit.risk fact., sev.  807443-018: 100 mg, 100, R303,81  Adults incl.elderly: Init: 25 mg nightly x1 wk. Subseq. incr.at 1-2 wkly.
   seiz./neurolog.impairm./anticonvuls. ther. poss.risk fact., SLE, hypoal-  807451-002: 300 mg, 100, R758,48  interv.by incr.of 25-50 mg/ day & admin.in 2 div.dos.guid.by clinic.out-
   buminaem., liv. dysfunct., dr.to be alert.to any signs of hepatotoxic.,   807478-008: 400 mg, 100, R758,48  come. Recomm. init.target dos: 100 mg/day & max. recomm. dly.dos.
   bld.lev.of enzym.induc.anti-epilept.in combin. ther., monit.phenytoin   is 500 mg. Some pts.toler. 1 000 mg /day.
   plasma lev./free form eval., monit.concom.carbamazepine toxic.esp.   (S3) TABS, 35/2.5/0099  Adjunct.ther: Adults: Recomm.to be init.at low. dos. then titr.to
                                705262-001: 600 mg, 100, R1 441,07
   init., poss.ser.tox.dermatolog.reacts.with lamotrigine, monit.through.  effect.dos. Init.25-50 mg in even. for 1 wk then incr.at wkly.interv.by
   first 15 days of combin. phenobarb. ther.with immed.reduct.of phe-  Dosage: May be used with phenobarbit., phenytoin, valproic acid   25-50 mg/day in 2 div. dos. Titr.to be guid.by clinic.outcome. Somet.
                                & carbamazepine without concern for alterat.in plasma or ser.conc.
   nobarb. dos. if sedat.occurs & determ.plasma lev., monit. concom.   of gabapentin/ other agents. Do not allow more than 12 hrs. betw.  effic. achiev. with once/day dos. Effect. dos. usual. with.range of
   primidone, monit.bld.lev.with carbapenem antibiot.  dos.to prev.breakthrough convuls.  200-400 mg dly in 2 div. dos. Up to max.800 mg/day may be reqd.
   Drug interactions: Incr.haemorrh.risk with anticoags. & thrombolyt.  Adults & childr.over 12 yrs: Titrate to effect.dos. Usual effect.dos:   Contraindications: Safety & effic.in childr.und. 12 yrs. not est., pregn.
   agents, valproate free ser.lev.incr.by high.prot. bound agents, anti-  Side effects: Fatig., asthen., injury, vir.infect., CNS/ psych.disords.,
   coag. eff.of vit.K depend.fact.anticoags.incr., poss. absence status   900-1 800 mg/day in 3 div.dos. with interv.of not more than 12 hrs.   dizzin., trem., co-ordin.probl., GI disturbs., pancreatit., somnol., psy-
                                If discont./ add. an altern.medicat.do so grad.over a minim.of 1 wk.
   epilept.with clonazepam, decr. conc. with concom.anti-epilept.with   chos., suic. ideas, weight decr., eye disords.incl.nystagm., ac. sec-
   enzym.induc. eff., decr.phenytoin plasma conc., incr.phenytoin free   Contraindications: Safety & effic.in childr.und. 12 yrs. not est.,   ond.angl.-clos.glauc., tinnit., rhinit., pharyngit., pneumon., dyspn.,
                                pregn., breast feed., sev.imp.ren. funct.
   form, poss.potent.tox.eff.of carbamazepine, carbamazepine & phe-  bld.dyscras., thromboembol. events, purpura, nephrolithias., ren./
   nytoin decr.ser.lev., lamotrigine metab.inhibit., phenobarb.plasma   Side effects: Leukopen., amblyop., diplop., GI disturbs., dental ab-  hepat.fail., haematur., dysur., urin.freq., incont., hepatit., skin reacts.
                                norm., fatig., fev., periph.oed., vir./ resp.infect., abras., fract., weight
   conc.incr., incr.CNS eff./low.of seiz.thresh.with MAOI/neurolept./  incl. erythema multiforme/Stev.-Johns. syndr./ tox.epiderm.necro-
   other antidepress., reduc.ser. conc.& low.seiz.thresh.with meflo-  incr., WBC decr., incr.appet., back pain, myalg., twitch., CNS effs.   lys.& pemphig., incr. sweat., gingivit., hypotens.
                                incl.nystagm.& trem, dysarthr., psych.effs., vasodilat., impot., cough.,
   quine/chloroq., rais. zidovudine plasma conc., cimetid.& erythro-  Warnings and special precautions: Unknown if excret.in breast
   myc. poss.incr.ser.lev., decr.bld.lev.somet. assoc.with convuls.with   pharyngit., rhinit., acne, prurit., rash, thrombocytopen., palpitat., chest   milk, monit.phenytoin lev., concom. digox./ OC’s/pioglitazone, diab.
   carbapenem antibiot., primidone plasma lev.incr., CNS depress.eff.  pain, tinnit., pancreatit., hepatit., jaund., allerg.reacts. incl. anaphy-  mellit., avoid CNS depress./alcoh./agents predispos.to nephrolithias.,
   incr. with benzodiazep.      lax.& hypersens.incl.syst.reacts.with eosinophil. & DRESS sympts.,   grad.withdr., ren./hepat.impairm., ren. stone format.risk, concom.
   See also MDR page 197.       rhabdomyolys., movem. disords., hallucinat., alopec., erythema mul-  agents predispos.to nephrolithias., adeq.hydrat., condit./ther. pre-
                                tiforme, Stev.-Johns.syndr., ac.kidn.fail., urin. incontin., sudd./unex-  dispos. to acidos., eval.bicarb.lev.dur.ther.& dos. reduct./discont.if
   NAVALPRO CR, (Aspen Pharmacare: Pharma) Brimpharm [P/S]  plain.death., breast hypertrophy, gynaecomast.  metabol. acidos.devel./ persist., discont.ther./appropr.meas.reduc.
   Sodium valproate and valproic acid (equiv to sod. valproate)  Special precautions: Elderly, imp.ren.funct., lact. intol.  IOP if ac. myopia assoc.with second.clos.angl.glauc. occurs, potent.
   Indications: Gen.epilep.partic.with absence/ myoclon./ ton.-clon./  Warnings: Poss.status epilept.with abrupt withdraw., not consid.ef-  teratogen.risk, OC’s to contain not less than 50 ug of oestrog./use
   aton.& mix.patt.seiz., part. epilep.with simple or complex seiz./sec-  fect.in absence seiz. treatm., observ.for CNS depress.with concom.   alt.non-hormon. contracept.
   ond.gen. seiz & specif.syndr.eg.West & Lennox Gastaut, treatm.&   morphine, eval.immed.if early signs of hypersens. pres & discont.if   Drug interactions: Poss.incr.phenytoin plasma conc., decr.plasma
   prev.of mania assoc.with bipol.disords.  alt.etiology not est., admin.2 hrs. bef./ aft.antacid admin.  conc.with phenytoin & carbamazepine, decr.ser.digox.lev., plasma</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page68.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page64.html">64</a>&nbsp;&nbsp;&nbsp;<a href="page65.html">65</a>&nbsp;&nbsp;&nbsp;<a href="page66.html">66</a>&nbsp;&nbsp;&nbsp;<a href="page67.html">67</a>&nbsp;&nbsp;&nbsp;<a href="page68.html">68</a>&nbsp;&nbsp;&nbsp;<a href="page69.html">69</a>&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>
             </td>
             <td width="35%"><a href="page70.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page70.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
